Facility Tour 8:30 a.m. to 9:00 a.m.
Registration & Continental Breakfast 9:00 a.m. to 9:40 a.m.
Introduction 9:40 a.m. to 10:00 a.m.

          Program Moderator & Chair: Andrew T. Hoyne, Partner, Armstrong Teasdale LLP
Morning Sessions 10:00 a.m. to 12:30 p.m.

10:00 a.m. to 11:15 a.m. - Funding Growth and Innovation
To be competitive in these industries, companies must continually focus on ensuring that they have sufficient funds readily available to capitalize on growth opportunities. This panel will discuss public and private funding of life science and healthcare technology companies, including state funding available for research and development. Also, this panel will explore access to public markets through non-traditional techniques, such as "reverse mergers."

 
Moderator:

Derek Rapp, CEO, Divergence, Inc.

 
Panelists:

Gian Cavallini, Director, Investment Banking for A.G. Edwards & Sons, Inc.
Pamela G. Boone, CFO, Synergetics, Inc.
Honorable Sarah Steelman, Missouri State Treasurer

 

11:15 a.m. to 12:30 p.m. - Capturing Value Through Intellectual Property
Innovation is crucial for all companies, especially those in the life sciences and healthcare technology sectors. Panelists will share their thoughts on how companies can best develop, protect and exploit their intellectual property, which can be their most strategic asset.

 
Moderator:

Brian Stierwalt, Chief Intellectual Property Counsel, Sigma-Aldrich Corporation
 
Panelists:

Carl Horton, Senior Counsel, Global Intellectual Property, GE Healthcare
Patrick Rasche, Practice Group Leader, Intellectual Property Practice Group, Armstrong Teasdale LLP
Kevin Conroy, Vice President, General Counsel and Secretary, Third Wave Technologies, Inc.
Luncheon 12:30 p.m. to 2:00 p.m.

     Opening Remarks: Kenneth F. Teasdale, Chairman, Armstrong Teasdale LLP

12:30 p.m. to 2:00 p.m. - China's Emerging Role in the Life Sciences Arena
China's increasing role in the world's economy is a given as is the increasing role of life sciences in Asia. This presentation by Charles Freeman, former Assistant United States Trade Representative for China, will discuss the impact and opportunities created by China's emerging position in the life science industry.

 
Keynote Speaker:

Charles W. Freeman III, Managing Director, China Alliance
Afternoon Sessions 2:00 p.m. to 4:30 p.m.

2:00 p.m. to 3:15 p.m. - Advancing Healthcare Through Innovative Collaboration
As the technology used by life science and healthcare technology companies becomes more complex and the need and opportunity for increasing the pace of innovation arises, industry participants from differing sectors are coming together in innovative ways to bring their different skill-sets to bear. Panel participants will share their views on the benefits and pitfalls of such collaboration.

 
Moderator:

Christina J. Shasserre, V.P. Strategic Marketing & Business Development, Sigma-Aldrich Biotechnology
 
Panelists:

Michael G. Douglas, Ph.D., Associate Vice Chancellor for Research Director, Office of Technology Management, Washington University
Gregory J. Downing, D.O., Ph.D., Director, Office of Technology and Industrial Relations, Office of the Director, National Cancer Institute

 

3:15 p.m. to 4:30 p.m. - Exploring the Intersection of Policy and Science
Understanding the government's policy goals is key in developing effective business plans for life science and healthcare technology companies. In this session, attendees will learn about federal and state regulation of research, development and new technologies and the impact certain legislation has had and will have on the advancement of science and medicine. Perspectives will be provided by representatives from the government, academia and industry.

 
Moderator:

William Applegate, Government Relations Director, Armstrong Teasdale LLP
 
Panelists:

Roger N. Beachy, Ph.D., President, Donald Danforth Plant Science Center; Chairman, Missouri Governor's Advisory Council on Plant Biotechnology
Congressman Russ Carnahan (D-Mo), Representing Missouri's 3rd Congressional District
Jeffrey Crippin, M.D., Professor and Director, Washington University School of Medicine Liver Transplant Program Director and Chair of the American Society of Transplantation Public Policy Committee
Facility Tour 4:30 p.m. to 5:00 p.m.
Reception 4:30 p.m. to 5:30 p.m.
 

 

Printer Friendly Version